Publication | Open Access
Impaired ADAMTS9 secretion: A potential mechanism for eye defects in Peters Plus Syndrome
32
Citations
48
References
2016
Year
Ocular DiseaseHuman GrowthGeneticsImmunodeficienciesPathologyImpaired Adamts9 SecretionMolecular GeneticsProtein GeneticsTranscriptional RegulationMendelian DisorderBiochemical GeneticsCraniofacial DevelopmentAdamts9 SecretionProteomicsMurine Adamts9Eye DefectsNeurogeneticsMolecular SignalingOphthalmologyInherited Metabolic DiseaseOcular PathologyCorneal OpacityGene ExpressionDevelopmental BiologyGenetic DisorderNatural SciencesPeters Plus SyndromeMedicine
Peters Plus syndrome (PPS), a congenital disorder of glycosylation, results from recessive mutations affecting the glucosyltransferase B3GLCT, leading to congenital corneal opacity and diverse extra-ocular manifestations. Together with the fucosyltransferase POFUT2, B3GLCT adds Glucoseβ1-3Fucose disaccharide to a consensus sequence in thrombospondin type 1 repeats (TSRs) of several proteins. Which of these target proteins is functionally compromised in PPS is unknown. We report here that haploinsufficiency of murine Adamts9, encoding a secreted metalloproteinase with 15 TSRs, leads to congenital corneal opacity and Peters anomaly (persistent lens-cornea adhesion), which is a hallmark of PPS. Mass spectrometry of recombinant ADAMTS9 showed that 9 of 12 TSRs with the O-fucosylation consensus sequence carried the Glucoseβ1-3Fucose disaccharide and B3GLCT knockdown reduced ADAMTS9 secretion in HEK293F cells. Together, the genetic and biochemical findings imply a dosage-dependent role for ADAMTS9 in ocular morphogenesis. Reduced secretion of ADAMTS9 in the absence of B3GLCT is proposed as a mechanism of Peters anomaly in PPS. The functional link between ADAMTS9 and B3GLCT established here also provides credence to their recently reported association with age-related macular degeneration.
| Year | Citations | |
|---|---|---|
Page 1
Page 1